Skip to content

Side by side

CJC-1295 vs SS-31

Both are discussed for anti-aging & longevity. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

CJC-1295 and SS-31 compared on what BioAlmanac records.
 CJC-1295SS-31
What it isA GHRH analogue that raises growth hormone by amplifying the body's own release signal. Sold in two forms whose durations differ by two orders of magnitude.A mitochondria-targeting peptide that reached phase 3 and missed its primary endpoints. The most rigorously tested compound on this site, and a cautionary tale about mechanism.
EvidenceHow much human evidence exists, not how well it works.Early human trialsClinical trials
Regulatory statusReviewed 2026-08-12Not approved for human use in the United States. The FDA has identified CJC-1295 as a substance raising concerns for use in compounded preparations. Sold only as a research chemical.Not approved for any indication. Elamipretide has been through phase 3 clinical trials that did not meet their primary endpoints. Development has continued in narrower rare-disease indications. Material sold as SS-31 is a research chemical, not the clinical product.
RoutesSubcutaneousSubcutaneous
Half-life0.5 hours2.5 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$2.40/mg$2.20/mg
Median per mg$7.25/mg$4.39/mg
Vendors with a price4028
Storage once mixedRefrigerated at 2–8 °C. Do not freeze once mixed.Refrigerated at 2–8 °C. Do not freeze once mixed.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.